Skip to main content

Animations

MJFF Publications

5491 - 5500 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2021
  • 2024
  • 2015
  • 2017
  • 2019
  • 2018
  • 2015
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1813365115
    Citation Count: 83
  • Summary Details
    OPEN
    Title: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28472
    Citation Count: 67
  • Summary Details
    RESTRICTED
    Title: An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks
    Journal Name: Digital Signal Processing
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.dsp.2024.104407
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Intact working memory in non‐manifesting LRRK2 carriers – an fMRI study
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13120
    Citation Count: 20
  • Summary Details
    OPEN
    Title: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression
    Journal Name: PROTEOMICS – Clinical Applications
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/prca.201700045
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.022
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
    Journal Name: Archives of Toxicology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00204-018-2222-z
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Compensatory neural mechanisms in cognitively unimpaired Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nd
    DOI - Digital Object Identifier: 10.1002/ana.24585
    Citation Count: 71
  • Summary Details
    RESTRICTED
    Title: Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentary
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.015
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105885
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.